Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by GreenInvestor9on Nov 11, 2016 10:32am
297 Views
Post# 25449354

RE:RE:RE:RE:Boourns

RE:RE:RE:RE:Boourns
Jake50 wrote:
At the end of the day, we are talking about dips that are pennies.  Aphria is top two in an emerging industry, so you can play the dips but you are risking the loss of good opportunities (as someone posted yesterday that they sold around $4.00 hoping to get a lower entry point - poor fella).  Just sit and watch your money grow!


I agree with you Jake - especially in the long-term. I'm actually very (pleasantly) surprised at the movement in the stock today. I have a hard time not flipping some shares out though. As every time I've seen a bought deal the share price will (eventually) return to the offer price.

But again, from an investment standpoint I'm with you 100%
GLTA
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities